iPath Pure Beta S&P GSCI-Weighted ETN
SBV
SBV was delisted on the 3rd of April, 2018.
2 hedge funds and large institutions have $60K invested in iPath Pure Beta S&P GSCI-Weighted ETN in 2014 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
650% more capital invested
Capital invested by funds: $8K → $60K (+$52K)
100% more funds holding
Funds holding: 1 → 2 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$24.7K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$24.3K |
Top Sellers
SBV Hedge Fund Activity: Q1 2014 in Review
2 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in iPath Pure Beta S&P GSCI-Weighted ETN (SBV) for Q1 2014, worth a combined $60K — up 650% from $8K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SBV positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $24.7K.
- 2 institutional investors held iPath Pure Beta S&P GSCI-Weighted ETN (SBV) as of Q1 2014, up from 1 in Q4 2013.
- Funds reported $60K of iPath Pure Beta S&P GSCI-Weighted ETN stock for Q1 2014, up 650% quarter-over-quarter.
- 1 fund opened new iPath Pure Beta S&P GSCI-Weighted ETN positions in Q1 2014 and 0 closed out, a net change of +1 holder.
- The largest iPath Pure Beta S&P GSCI-Weighted ETN buyer in Q1 2014 was Tower Research Capital (TRC), an estimated $24.7K added.
Based on aggregated 13F filings for Q1 2014.